NCI Cancer Bulletin: A Trusted Source for Cancer Research NewsNCI Cancer Bulletin: A Trusted Source for Cancer Research News
January 25, 2005 • Volume 2 / Number 4 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe

The information and links on this page are no longer being updated and are provided for reference purposes only.


Changes to PDQ Enhance Online Cancer Information
NCI's Physician Data Query (PDQ®) evidence-based cancer information summaries, which are available on NCI's Web site ( in both health professional and patient-oriented versions, have been refashioned to provide more Web-friendly presentations. In addition, users of the summaries are now offered a variety of view and print options, and illustrations of key medical concepts are being included in the patient-oriented summaries.

All PDQ summaries are divided into sections for easy navigation and scanning, and they can be viewed and printed as entire documents or by selected section. Tabs at the top of each summary allow easy switching between the health professional, patient-oriented, and Spanish (if available) versions. The health professional summaries include reference lists with links to literature citations in the National Library of Medicine's PubMed database.

The patient-oriented summaries use less-technical language and "information mapping" methods, such as boxed key points, bulleted lists, and other formatting techniques, to enhance readability. Key points highlight critical concepts and link to explanatory information in the body of the text. Medical and scientific terms in the patient-oriented summaries are linked to entries in the NCI Dictionary and, if a document is printed, all linked terms and their definitions are included in the printout.

Ruoslahti Awarded Japan Prize
Dr. Erkki Ruoslahti, distinguished professor at the Burnham Institute in La Jolla, Calif., has been awarded the 2005 Japan Prize in the category of cell biology. Dr. Ruoslahti will share the prize, 50 million yen (approximately $487,000 USD), with Dr. Masatoshi Takeichi, Director of the RIKEN Center for Developmental Biology in Kobe, Japan. The award will be presented in Tokyo on April 20 as part of "Japan Prize Week."

The Japan Prize is awarded annually to people from all parts of the world whose original and outstanding achievements in science and technology are recognized as having advanced the frontiers of knowledge and served the cause of peace and prosperity for mankind.

Dr. Ruoslahti is being recognized for his seminal contributions to the cell adhesion field, which include the discovery and molecular definition of the site at which cells attach to one another: the peptide RGD. His discoveries were supported over a 20-year continuum with funding from NCI. Dr. Ruoslahti's discoveries in cancer biology are also relevant to a broad range of cell behaviors that are involved in managing heart attack, stroke, osteoporosis, and angiogenesis.

CCR Fellows to Participate in Harvard Symposium
The Harvard Medical School Minority Faculty Development Program and the Biomedical Science Careers Program (BSCP) will hold the fourth annual New England Science Symposium on March 4. Four postdoctoral fellows in NCI's Center for Cancer Research have been invited to present their research. The aim of the symposium is to encourage African American, Hispanic American, and American Indian/Alaska Native medical/dental, college, graduate school, and postdoctoral fellows involved in biomedical or health-related scientific research to present their research projects.

The fellows are Dr. Magnus Che, Laboratory of Cellular Oncology (poster presentation); Dr. Denise Perry Simmons, Laboratory of Cellular Carcinogenesis and Tumor Promotion (oral presentation); Dr. Karl Thompson, Laboratory of Molecular Biology (alternate oral presentation); and Dr. Sam Waters, Cancer and Developmental Biology Laboratory (oral presentation).

Global Initiative To Update Guidelines for Breast Health
The second biennial meeting of the Breast Health Global Initiative (BHGI) took place in Bethesda, Md., January 12-14. A collaboration of 11 national and international organizations, BHGI is sponsored by the Fred Hutchinson Cancer Research Center and co-sponsored by the Susan G. Komen Breast Cancer Foundation to develop evidence-based, economically feasible, and culturally appropriate guidelines to improve breast health outcomes for countries with limited health care resources.

Sixty-seven participants from 33 countries with high-, mid-, and low-level resources attended the meeting, including health care professionals, epidemiologists, sociologists, economists, ethicists, patient advocates, and representatives of health organizations and health ministries. NCI's Office of International Affairs hosted the meeting and provided travel scholarships for some participants from developing countries. Based on this meeting, updated BHGI guidelines will be prepared and published this fall. The guidelines will address early detection, diagnosis, and treatment of breast cancer, as well as health care systems and public policy. For more information about BHGI, go to